← back to search

Patrick Twomey

University of California System · IE
Area of research
Oncology · Physiology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Nutrition and Health in Aging, Immunotherapy and Immune Responses, and Clinical Nutrition and Gastroenterology.
h-index
25
citations
3,169
works
50
NIH funding
primary concept
Medicine
email

Recent publications

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Nature Medicine 2025cited by 89position: middledoi
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
Molecular Therapy 2020cited by 268position: middledoi
Abstract CT302: Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors
Cancer Research 2020cited by 63position: middledoi
Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
Cancer Research 2020cited by 57position: middledoi
Elevated Levels of Proliferating and Recently Migrated Tumor-associated Macrophages Confer Increased Aggressiveness and Worse Outcomes in Breast Cancer
Annals of Surgical Oncology 2012cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2012–2012)Vickram J. Tandon · Harvard University1 papers (2012–2012) · 1 papers (2012–2012)Onouwem Nseyo · University of California System1 papers (2012–2012)Amy P. Moore · University of California System1 papers (2012–2012)Joe W. Gray · Directorate-General for Interpretation1 papers (2012–2012)Benjamin Wu · Georgetown University1 papers (2020–2020)Rita A. Mukhtar · University of California, San Francisco1 papers (2012–2012)Joy Hsu · Weill Cornell Medicine1 papers (2020–2020)Iraj Hosseini · Gene Therapy Laboratory1 papers (2020–2020)Dan H. Moore · Arkansas Department of Agriculture1 papers (2012–2012)Anand Rotte · University of Tübingen1 papers (2020–2020)O. I. Olopade · University of Chicago1 papers (2012–2012)Laura J. Esserman · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2012–2012)Ben‐Quan Shen · Gene Therapy Laboratory1 papers (2020–2020)Michael S. McGrath · University of California, San Francisco1 papers (2012–2012)Frederick L. Baehner · Maxygen (United States)1 papers (2012–2012)Sandhya Girish · Rush University Medical Center1 papers (2020–2020)Colby S. Shemesh · Amgen (United States)1 papers (2020–2020)Michael J. Campbell · University of California, San Francisco1 papers (2012–2012)